Unmasking Conformationally Adaptable Lipids as Drug Receptors

Area of Science:

• Biochemistry
• Membrane Biophysics
• Pharmacology

Background:

• Lipophilic drugs interact with cell membranes, but specific binding mechanisms are not fully understood.
• Cholesterol is known to influence membrane properties and drug interactions.
• The role of adaptable lipids as drug receptors requires further investigation.

Purpose of the Study:

• To investigate the potential of conformationally adaptable lipids as receptors for lipophilic drugs.
• To elucidate the binding mechanisms between specific lipophilic drugs and membrane lipids.
• To propose a model explaining these drug-lipid interactions.

Main Methods:

• Nearest-Neighbor Recognition (NNR) measurements to quantify drug-lipid complex formation.
• Biochemical studies on human red blood cells using 63 amphipathic molecules.
• Raman spectroscopy to analyze lipid conformational changes upon drug binding.

Main Results:

• Nearest-Neighbor Recognition (NNR) data confirmed 1:1 complex formation between chloroform, halothane, isoflurane, and 1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC) in cholesterol-rich membranes.
• Biochemical studies revealed similar interaction patterns with various amphipathic molecules.
• Raman spectroscopy indicated increased gauche conformations in DPPC hydrocarbon chains upon chloroform complexation, supporting a 'wrap-around' model.

Conclusions:

• Conformationally adaptable lipids act as receptors for lipophilic drugs, effectively outcompeting cholesterol.
• A 'wrap-around' model explains how these lipids bind lipophilic agents.
• Recognizing adaptable lipids as drug receptors can improve lipophilic drug design and optimization.